AC Immune SA - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ACIU Nasdaq 2834 www.acimmune.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for AC Immune SA

AC Immune (ACIU) Beats Q2 Earnings and Revenue Estimates - Aug 5th, 2026 7:55 am
AC Immune First Half 2026 Financial and Corporate Update - Aug 5th, 2026 5:00 am
AC Immune to Showcase Neurodegenerative Disease Pipeline with Three Presentations at AAIC® 2026 - Jul 7th, 2026 5:00 am
AC Immune Reports Interim 12-Month Data from Phase 1b/2 ABATE Trial of ACI-24 in Prodromal Alzheimer’s Disease - Jun 30th, 2026 5:00 am
ImmunityBio (IBRX) Moves 11.8% Higher: Will This Strength Last? - Jun 29th, 2026 5:56 am
June 2026 Penny Stocks To Watch For Potential Growth - Jun 15th, 2026 12:05 pm
INDV and the Shift to Long-Acting Opioid Use Disorder Care in 2026 - Jun 12th, 2026 8:20 am
Is Indivior Stock a Buy After Higher 2026 Guidance? - Jun 12th, 2026 8:15 am
INDV Stock: What Sublocade Growth Signals for 2026 - Jun 12th, 2026 8:13 am
AC Immune to Receive Research Grant from Goradia Family for Development of ACI-7104 in Parkinson’s Disease - Jun 11th, 2026 5:00 am
AC Immune (ACIU) Forms 'Hammer Chart Pattern': Time for Bottom Fishing? - Jun 3rd, 2026 7:55 am
AC Immune Presents New Phase 1 Data Indicating Higher Uptake of TDP-43 PET Tracer ACI-19626 in Patients with ALS - May 22nd, 2026 5:00 am
AC Immune (ACIU) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - May 14th, 2026 7:55 am
Assertio accepts new buyout bid; AI biotech Isomorphic banks $2B - May 13th, 2026 4:27 am
AC Immune Announces Retirement of CEO Dr Andrea Pfeifer at Upcoming AGM - May 12th, 2026 5:00 am
AC Immune (ACIU) Reports Q1 Loss, Tops Revenue Estimates - Apr 30th, 2026 6:30 am
AC Immune First Quarter 2026 Financial and Corporate Updates - Apr 30th, 2026 5:05 am
AC Immune Initiates Final Cohort in Ongoing Phase 1b/2 ABATE Trial of Anti-Abeta Active Immunotherapy to Treat Alzheimer's Disease - Apr 30th, 2026 5:00 am
Leerink Says AC Immune (ACIU) Eli Lilly Tau Program Amendment Is Great News - Apr 12th, 2026 12:46 pm
ACIU Stock Rallies 16.3% in a Week: Here's What You Need to Know - Apr 9th, 2026 8:29 am